Dr. Caroline Fichtner

Principal / Authorized Signatory

Dr. Caroline Fichtner

Principal / Authorized Signatory

Along with her experience in VC, biophysicist Dr Caroline Fichtner also spent many years working at the Max Planck Institute for Bioinorganic Chemistry in Mülheim an der Ruhr. At HTGF, the authorized signatory is responsible for the financing and development of technology start-ups in the life sciences field.


Posts & mentions

4. October 2023

Inovedis Announces Close of Series A Funding Round 

Raises $4 Million in New Equity Funding  ALBSTADT, Germany – October 4, 2023 – Inovedis GmbH, a medical technology start-up dedicated to offering innovative solutions that contribute both to optimized patient care as well as minimizing the complexity of surgical interventions, announced the successful close of a Series A funding round totaling $4 million. This funding was supported by participation from all of Inovedis’s initial seed round investors including High-Tech Gründer
24. August 2023

High-tech for sustainable agriculture

Call for Applications – AgriTech Pitch Day 2023 in Hannover Bonn and Hannover, August 24, 2023 – The AgriTech Pitch Day 2023 on September 28 in Hannover will focus on the future of agriculture. The event is organized by High-Tech Gründerfonds (HTGF) and RootCamp, with RootCamp serving as host. Founders of agricultural technology companies (AgriTech) will have the exclusive opportunity there to present their innovative solutions and ideas to a select group of investors, corporat
14. June 2023

DNTOX receives €1.4 million seed funding for non-animal testing of chemicals

The life science startup enables non-animal testing of chemicals for neurotoxicity.  DNTOX receives €1.4 million from High-Tech Gründerfonds (HTGF), private investors Barbara Korte-Sturm and Nikolaus Sturm, Bool Capital, and AQAL Capital. The new capital will be used to set up the test laboratories in Düsseldorf, aim for GLP accreditation and launch the test battery on the market. Düsseldorf, June 14, 2023 – The Life Science startup DNTOX receives seed funding
HBOX Founding team
22. February 2023

MedTech startup HBOX Therapies receives €2.3m in seed funding for protective lung support

The medtech start-up develops innovative treatment method for patients with lung failure. HBOX Therapies receives €2.3 million in seed funding from TechVision Fonds (TVF), High-Tech Gründerfonds (HTGF) and business angel Prof. Dr. Peter Borges. The fresh capital will be used to develop and test a first prototype, marking an important step towards clinical trials. Aachen, 22 February 2023 – HBOX Therapies raises €2.3m in seed funding. The round is led by TVF, with pa
resolve logo
28. October 2022

Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography™ Workflow

Funding led by Patient Square Capital follows successful launch of groundbreaking system that delivers highest-resolution view of subcellular, single-molecule, spatial biology MONHEIM AM RHEIN, Germany – October 24, 2022 – Resolve Biosciences, the pioneer in Molecular Cartography™ technology, today announced it has secured a $71 million Series B financing. The latest round of funding was led by Patient Square Capital and included participation from EDBI, PS C
3. May 2022

Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies

MUNICH, GERMANY, May 3, 2022 – Tubulis today announced the successful completion of a €60 million (USD $63 million) Series B financing led by Andera Partners with participation from new investors Evotec and Fund+. All existing investors also participated in the round, including Bayern Kapital (with Wachstumsfonds Bayern 2), BioMedPartners, coparion, High-Tech Gründerfonds (HTGF), OCCIDENT and Seventure Partners. The new capital will be used to advance Tubulis’ proprietary pipeline of